0001179110-19-008261.txt : 20190701 0001179110-19-008261.hdr.sgml : 20190701 20190701192305 ACCESSION NUMBER: 0001179110-19-008261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190701 FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goyal Vikas CENTRAL INDEX KEY: 0001721017 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 19934791 MAIL ADDRESS: STREET 1: C/O SR ONE, LTD., 161 WASHINGTON ST. STREET 2: SUITE 500, EIGHT TOWER BRIDGE CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 9787296480 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 edgar.xml FORM 4 - X0306 4 2019-07-01 0 0001679363 Morphic Holding, Inc. MORF 0001721017 Goyal Vikas C/O SR ONE, LIMITED 161 WASHINGTON STREET, SUITE 500 CONSHOHOCKEN PA 19428 1 0 0 0 Common Stock 2019-07-01 4 C 0 1469950 A 1469950 I By S.R. One, Limited Common Stock 2019-07-01 4 C 0 830489 A 2300439 I By S.R. One, Limited Common Stock 2019-07-01 4 P 0 333333 15.00 A 2633772 I By S.R. One, Limited Series A Preferred Stock 2019-07-01 4 C 0 1469950 D Common Stock 1469950 0 I By S.R. One, Limited Series B Preferred Stock 2019-07-01 4 C 0 830489 D Common Stock 830489 0 I By S.R. One, Limited Each share of the issuer's Series A Preferred Stock automatically converted into one share of the issuer's Common Stock on July 1, 2019 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-231837) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date. S.R. One, Limited, an indirect wholly-owned subsidiary of GlaxoSmithKline plc, is the record holder of the shares reported herein. Vikas Goyal holds the title of Principal at S.R. One, Limited and is an employee of GlaxoSmithKline LLC, a wholly-owned subsidiary of GlaxoSmithKline plc. Mr. Goyal disclaims beneficial ownership of all the shares held by S.R. One, Limited and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein. Each share of the issuer's Series B Preferred Stock automatically converted into one share of the issuer's Common Stock on July 1, 2019 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date. /s/ Robert Farrell as attorney-in-fact for Vikas Goyal 2019-07-01